Supplement Bioavailability Explained: Why Form Determines Effectiveness

Supplement bioavailability is the single most important variable that separates effective supplementation from expensive waste. It is defined as the fraction of an administered compound that reaches systemic circulation in an active form — and for many common supplements, this fraction varies from under 5% to over 80% depending entirely on the chemical form chosen. Two products with identical label doses can deliver radically different amounts of active ingredient to your cells, and the difference is almost entirely explained by form selection, not brand or price.

The Evidence Base

The science of bioavailability comes primarily from pharmacokinetic research — area-under-the-curve (AUC) studies that track serum concentrations over time after a controlled dose. For most minerals, these studies have been conducted as direct head-to-head comparisons between forms in human subjects. Magnesium glycinate versus oxide has been tested with measurable serum and urinary magnesium outcomes. The data is clear and reproducible: chelated forms consistently outperform inorganic salts for absorption. Veronese et al. (2021) confirmed clinically meaningful differences in serum magnesium elevation across forms. This is not theoretical — it shows up in blood levels. Gröber et al. (2015) provides a comprehensive review of magnesium forms and their clinical relevance, establishing the evidence base that form selection is not a minor detail.

How Bioavailability Is Measured

The gold standard measurement is a pharmacokinetic study in which participants receive a controlled dose and blood is drawn at multiple timepoints post-ingestion. The area under the plasma concentration-time curve (AUC) gives a composite measure of total absorption — it captures both the peak concentration and how long the compound remains in circulation. For minerals like magnesium, urinary excretion studies add a complementary dimension: if more magnesium appears in urine after a specific form, more of it was absorbed (the body does not excrete what it never absorbed).

Bioavailability varies enormously across supplement forms—the table below gives concrete examples of how form choice affects absorption:

For compounds like NMN, bioavailability measurement is more complex because the parent compound is rapidly converted to NAD+ intracellularly. Standard serum measurements often capture NAD+ and its metabolites rather than NMN itself, which is why interpreting NMN pharmacokinetic studies requires understanding the full conversion cascade. Irie et al. (2020) navigated this by measuring blood NAD+ and urinary metabolites simultaneously after oral NMN dosing, confirming systemic exposure. For stable small molecules and minerals, plasma AUC studies are more straightforward and the form comparisons more direct.

Relative bioavailability — comparing two forms against each other — is often more practically useful than absolute bioavailability (the precise percentage of dose absorbed). If glycinate delivers several times more elemental magnesium to circulation than oxide, the relative difference tells you which to buy. The exact percentage matters less than the order-of-magnitude difference in how much reaches your cells.

The Form Problem: A Tale of Two Magnesiums

Magnesium oxide is the cheapest, most widely sold magnesium salt. It is also one of the least absorbed, with bioavailability estimates ranging from 4–10% across studies. It is a bulk osmotic laxative at standard doses because unabsorbed magnesium draws water into the colon — this is why magnesium oxide products are sold as constipation aids. The low absorption is the feature for that application, not a flaw. But for anyone trying to correct magnesium deficiency or support neurological and sleep functions, magnesium oxide is the wrong tool.

Magnesium glycinate chelates magnesium to two glycine molecules. Glycine is absorbed via intestinal peptide transporters (PEPT1 and PEPT2), which are distinct from the ionic magnesium channels that become saturated at higher inorganic doses. This allows glycinate to use a high-capacity absorption route that bypasses the bottleneck limiting inorganic forms. Published pharmacokinetic comparisons consistently show superior serum magnesium levels with glycinate compared to oxide at equivalent elemental doses. The detailed magnesium form comparison quantifies how large this difference is in practice — often 4–5x more elemental magnesium reaching circulation from the same label dose.

This form-absorption relationship is not unique to magnesium. A full ranking of magnesium forms shows that citrate, malate, and taurate all substantially outperform oxide, with glycinate and L-threonate at the high end for different mechanistic reasons. Threonate uses a third pathway via monocarboxylate transporters, with evidence of preferential CNS penetration. Form selection for the right goal is not a minor optimization — it is a fundamental decision.

The Mechanism: Why Chelates Absorb Better

Inorganic mineral salts — oxide, sulfate, carbonate — rely on ionic mineral channels for intestinal absorption, primarily in the proximal small intestine. These channels become saturated at moderate doses. Increasing the dose does not increase absorption beyond the saturation point because the transport proteins are rate-limiting. Unabsorbed mineral continues into the colon, where it can cause GI distress, loose stools, or diarrhea — symptoms commonly attributed to magnesium but actually reflecting inadequate form selection rather than magnesium itself being problematic.

Amino acid chelates exploit a different, higher-capacity absorption route. The metal-amino acid complex is recognized as a small peptide by intestinal peptide transporters, particularly PEPT1. These transporters handle a broader range of substrates and have different saturation kinetics than ionic mineral channels. They also operate across a wider pH range, making chelates less sensitive to gastric acid variability. This matters significantly for older adults, in whom hypochlorhydria (low stomach acid) is common and significantly impairs inorganic mineral absorption. Zhang et al. (2016) found that magnesium form made a meaningful difference in blood pressure response, consistent with higher effective doses reaching systemic circulation.

Phospholipid encapsulation — liposomal delivery — provides yet another mechanism: the active compound is packaged in a lipid bilayer that fuses with cell membranes, bypassing aqueous intestinal absorption entirely. Liposomal forms are expensive but justified for compounds with particularly poor aqueous solubility or first-pass metabolism that limits standard oral bioavailability.

Absorption Factors Beyond Chemical Form

Form is the largest single variable in bioavailability, but several other factors meaningfully affect how much of your supplement reaches systemic circulation:

Food co-administration: Fat-soluble vitamins (A, D, E, K) require dietary fat for micelle formation and absorption via chylomicrons. Taking vitamin D on an empty stomach with no dietary fat significantly reduces absorption. Conversely, most water-soluble compounds and minerals are not clearly benefited or harmed by food, and some (like ashwagandha) have evidence of improved tolerability when taken with food without compromising absorption.

Stomach acid: Adequate gastric acid is required to ionize inorganic mineral forms for absorption in the small intestine. People with hypochlorhydria — common in adults over 60 and in anyone taking proton pump inhibitors — may have significantly impaired absorption of oxide and carbonate salts, while amino acid chelates are less affected because they do not require ionization before transport. This is a frequently overlooked source of supplement failure. Many of the reasons supplements do not seem to work trace back to form or gastric acid issues rather than the compound itself being ineffective.

Competing compounds: Calcium and magnesium compete for absorption via shared divalent mineral transporters. Taking large doses of both simultaneously reduces the absorption of each. Polyphenols in tea and coffee (tannins and chlorogenic acids) can chelate minerals and reduce their bioavailability when consumed simultaneously. Iron and zinc compete for the DMT1 (divalent metal transporter 1). These interactions are reproducible and worth managing through timing rather than assuming the supplement is ineffective.

GI transit time and microbiome: Gut transit time affects the contact duration between supplement and absorptive epithelium. Dysbiosis and intestinal permeability changes can alter both the absorptive surface area and the enzymatic environment that prepares some compounds for uptake. While this is harder to control directly, it explains why some people respond poorly to supplements that work well in most research populations.

Bioavailability in the Context of NMN and NAD+ Precursors

NMN pharmacokinetics do not fit the standard mineral absorption model. NMN is a nucleotide that enters cells via the Slc12a8 transporter (characterized in murine tissue) and possibly other routes in humans. Once intracellular, it is rapidly phosphorylated to NAD+. This means serum NMN levels rise and fall quickly after oral dosing — not because absorption is poor, but because conversion to NAD+ is efficient. Measuring plasma NMN alone understates the actual systemic effect.

Yoshino et al. (2021) confirmed that oral NMN at 250 mg/day for 10 weeks elevated skeletal muscle NAD+ in postmenopausal women — direct evidence that NAD+ precursor conversion is functionally effective at standard doses. The bioavailability question for NMN is therefore less about percent absorbed and more about intracellular conversion efficiency, which appears adequate at doses from 250–1000 mg. Bio:sudo Magnesium Glycinate uses a bisglycinate chelate specifically because the absorption advantage over oxide is quantifiable and clinically meaningful — the same critical thinking about form applies when evaluating any mineral supplement product.

Reading Labels for Bioavailability Signals

Most supplement labels do not state bioavailability directly. You infer it from the ingredient form name. For minerals, the chemical compound name following the mineral name is the critical signal: glycinate, bisglycinate, citrate, malate, and taurate indicate organic chelates or salts with meaningfully higher absorption than oxide, carbonate, and sulfate. For B vitamins, methylcobalamin (B12) and methylfolate (5-MTHF) do not require enzymatic conversion that some people with MTHFR gene variants perform poorly. Checking the form takes 10 seconds and is the highest-leverage label-reading habit.

Who Benefits Most from Understanding Bioavailability

• People who have tried supplements and seen no effect — form selection may fully explain the failure
• Older adults (55+) with reduced stomach acid affecting inorganic mineral absorption
• Anyone taking proton pump inhibitors or H2 blockers, which reduce gastric acid and impair ionization of oxide and carbonate forms
• People with GI conditions (IBS, low stomach acid, inflammatory bowel disease) where absorptive surface is already compromised
• Anyone taking multiple minerals simultaneously without awareness of competitive absorption dynamics
• People who are choosing between brands and assume higher price signals higher quality regardless of form

Practical Takeaways

• Form determines how much active compound reaches circulation — always check the form, not just the dose
• Magnesium glycinate or bisglycinate delivers substantially more elemental magnesium to cells than oxide at equivalent label doses
• Fat-soluble vitamins (A, D, E, K) must be taken with dietary fat for adequate micelle formation and chylomicron absorption
• Amino acid chelates are the preferred mineral form for older adults and anyone with GI issues or low stomach acid
• Separate calcium and magnesium supplementation by at least 2 hours to avoid competitive absorption
• Coffee and tea tannins chelate minerals — take mineral supplements away from these beverages for best absorption

Bottom Line

Supplement bioavailability is determined primarily by chemical form, with meaningful contributions from food timing, gastric acid, GI transit, and competing compounds. For minerals, the gap between high-bioavailability chelates and low-bioavailability inorganic salts can be 5–10x — easily large enough to explain why the same compound produces no effect in one person and clear results in another. Form selection is the single highest-leverage decision in supplement purchasing, and it takes 10 seconds to evaluate once you know what to look for.

References

1. Schwalfenberg GK, Genuis SJ. "The importance of magnesium in clinical healthcare." Scientifica. 2017;2017:4179326. [Source]
2. Abbasi B, et al. "The effect of magnesium supplementation on primary insomnia in elderly." J Res Med Sci. 2012;17(12):1161–1169. [Source]
3. Gröber U, et al. "Magnesium in prevention and therapy." Nutrients. 2015;7(9):8199–8226. [Source]
4. Zhang X, et al. "Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials." Hypertension. 2016;68(2):324–333. [Source]
5. Veronese N, et al. "Effect of magnesium supplementation on oxidative stress in humans: a systematic review." Eur J Nutr. 2021;60(4):2049–2063. [Source]